1. Home
  2. DERM vs SPOK Comparison

DERM vs SPOK Comparison

Compare DERM & SPOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Journey Medical Corporation

DERM

Journey Medical Corporation

HOLD

Current Price

$7.11

Market Cap

194.9M

Sector

Health Care

ML Signal

HOLD

Logo Spok Holdings Inc.

SPOK

Spok Holdings Inc.

HOLD

Current Price

$10.51

Market Cap

228.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
DERM
SPOK
Founded
2014
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
194.9M
228.7M
IPO Year
2021
2004

Fundamental Metrics

Financial Performance
Metric
DERM
SPOK
Price
$7.11
$10.51
Analyst Decision
Strong Buy
Hold
Analyst Count
3
1
Target Price
$12.67
$14.00
AVG Volume (30 Days)
338.9K
176.3K
Earning Date
05-13-2026
04-29-2026
Dividend Yield
N/A
11.31%
EPS Growth
34.72
2.74
EPS
N/A
0.09
Revenue
$61,858,000.00
$139,708,000.00
Revenue This Year
$39.72
$1.70
Revenue Next Year
$63.24
N/A
P/E Ratio
N/A
$117.44
Revenue Growth
10.20
1.49
52 Week Low
$4.31
$9.95
52 Week High
$9.56
$19.31

Technical Indicators

Market Signals
Indicator
DERM
SPOK
Relative Strength Index (RSI) 63.54 47.31
Support Level $7.00 $10.41
Resistance Level $7.69 $11.07
Average True Range (ATR) 0.44 0.31
MACD 0.06 0.00
Stochastic Oscillator 86.21 40.26

Price Performance

Historical Comparison
DERM
SPOK

About DERM Journey Medical Corporation

Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

About SPOK Spok Holdings Inc.

Spok Holdings Inc is a provider of healthcare communications. The company delivers clinical communication and collaboration solutions to help protect the health, well-being, and safety of people in the United States and abroad, on a limited basis, in Europe, Canada, Australia, Asia, and the Middle East. The company develops, sells, and supports enterprise-wide systems principally for healthcare and other organizations needing to automate, centralize, and standardize their approach to clinical and critical communications. The company offers its services and products to three market segments: healthcare, government, and large enterprise, with a greater emphasis on the healthcare market segment. Geographically, the company generates the majority of its revenue from the United States.

Share on Social Networks: